SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $700,943,407 | +12.4% | 5,782,449 | +6.1% | 0.46% | +18.3% |
| Q2 2023 | $623,869,537 | -7.8% | 5,447,667 | +11.0% | 0.39% | -13.0% |
| Q1 2023 | $676,528,232 | -13.4% | 4,908,204 | -18.6% | 0.45% | -20.1% |
| Q4 2022 | $781,073,641 | +9.0% | 6,028,016 | -53.5% | 0.56% | +4.1% |
| Q3 2022 | $716,775,059 | +32.2% | 12,955,978 | +79.1% | 0.54% | +43.3% |
| Q2 2022 | $542,171,000 | -7.0% | 7,232,672 | -3.0% | 0.37% | +33.1% |
| Q1 2022 | $582,678,000 | -10.7% | 7,458,582 | +2.9% | 0.28% | +3.3% |
| Q4 2021 | $652,496,000 | -4.6% | 7,245,862 | -2.1% | 0.27% | -9.0% |
| Q3 2021 | $684,205,000 | +27.6% | 7,398,598 | +7.3% | 0.30% | +30.6% |
| Q2 2021 | $536,015,000 | +16.5% | 6,894,765 | +11.7% | 0.23% | +9.0% |
| Q1 2021 | $459,992,000 | -30.4% | 6,171,863 | +59.2% | 0.21% | -31.6% |
| Q4 2020 | $660,758,000 | +19.1% | 3,875,676 | -1.9% | 0.31% | +6.2% |
| Q3 2020 | $554,781,000 | -4.4% | 3,950,552 | +9.2% | 0.29% | -11.3% |
| Q2 2020 | $580,081,000 | +68.3% | 3,617,829 | +2.7% | 0.33% | +37.6% |
| Q1 2020 | $344,715,000 | -15.7% | 3,523,983 | +11.1% | 0.24% | +13.4% |
| Q4 2019 | $409,145,000 | +135.6% | 3,170,682 | +37.5% | 0.21% | +122.3% |
| Q3 2019 | $173,638,000 | -58.1% | 2,305,340 | -15.5% | 0.09% | -58.2% |
| Q2 2019 | $414,532,000 | +30.5% | 2,728,082 | +2.3% | 0.22% | +27.8% |
| Q1 2019 | $317,766,000 | +58.3% | 2,666,043 | +44.9% | 0.18% | +37.5% |
| Q4 2018 | $200,755,000 | +204.3% | 1,839,594 | +350.4% | 0.13% | +265.7% |
| Q3 2018 | $65,964,000 | +20708.8% | 408,422 | +16917.6% | 0.04% | – |
| Q2 2018 | $317,000 | -85.2% | 2,400 | -93.1% | 0.00% | -100.0% |
| Q3 2016 | $2,149,000 | – | 35,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |